News

Valneva Expands its Commercial Operations with the Opening of its French Commercial Office

Valneva SE (“Valneva” or “the Company”) today announced a further expansion of its global commercial infrastructure with...

Sanofi und WKÖ präsentierten das 11. Jahrbuch für Gesundheitspolitik und Gesundheitswirtschaft

ExpertInnen diskutierten auf hochrangig besetzter Veranstaltung Trends, Perspektiven und Herausforderungen für die...

Valneva Announces End of Phase 2 Meeting with the FDA for its Chikungunya Vaccine Candidate

Valneva SE (“Valneva” or “the Company”) announced today that an End Of Phase 2 (EOP2) meeting has been scheduled with...

MedUni Vienna: Alzheimer's: New ultrasound technique significantly improves brain performance

n neurological diseases such as Alzheimer's disease, Parkinson's disease or Multiple Sclerosis, brain neurons are...

HOOKIPA’s Gilead Sciences Collaboration for HIV and HBV Therapeutic Vaccines Advancing Towards Clinical Entry

HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting...

Lexogen: QuantSeq-UMI Pipeline is Now Available on Partek® Flow®

QuantSeq is a 3’ mRNA-Seq library prep protocol, which is the method of choice for RNA-Seq gene expression analysis due...

MedUni Vienna: Genetic interventions as a radical means of controlling insect-borne diseases

UNESCO Chair for Bioethics meeting in MedUni Vienna's Josephinum on 8/9 January 2020

HOOKIPA Announces First Patient Dosed in Phase 1/2 Clinical Trial for HB-201 for the Treatment of Human Papillomavirus 16-Positive Cancers

HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting...

Theodor Billroth Prize for MedUni Vienna researchers

This year, Vienna Medical Association's Theodor Billroth Prize was divided equally between three researchers from MedUni...

MedUni Vienna: Shahrokh Shariat awarded Grand Central European Prize by City of Vienna Fund for Innovative, Interdisciplinary Cancer Research

Shahrokh Shariat, Head of the Department of Urology of MedUni Vienna/Vienna General Hospital, has been awarded the Grand...

Phenaris: 3rd place at i2b Business Plan Competition

We are happy to announce that our lead product ToxPHACTS has recently won us the 3rd place at the i2b Business Plan...

MedUni Wien: WWTF fördert Forschungsprojekte der MedUni Wien im aktuellen Life Science Call Imaging

Studien im Bereich der medizinischen Bildgebung zu Brustkrebs, Stoffwechsel und Chromosomen

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on then-current expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? Just send your contributions to news(at)lisavienna.at.